Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Sundry Debtors

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Sundry Debtors History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Sundry Debtors ₹4,963 Cr₹3,342 Cr₹1,858 Cr₹3,665 Cr₹3,101 Cr

What is the latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS ?

The latest Sundry Debtors ratio of GLENMARK PHARMACEUTICALS is ₹4,963 Cr based on Mar2026 Consolidated results.
Year Sundry Debtors
Mar2026₹4,963 Cr
Mar2025₹3,342 Cr
Mar2024₹1,858 Cr
Mar2023₹3,665 Cr
Mar2022₹3,101 Cr

How is Sundry Debtors of GLENMARK PHARMACEUTICALS Trending?

Years Sundry Debtors % Change
Mar2026 ₹4,963 Cr
48.52
Mar2025 ₹3,342 Cr
79.83
Mar2024 ₹1,858 Cr
-49.30
Mar2023 ₹3,665 Cr
18.19
Mar2022 ₹3,101 Cr -

Compare Sundry Debtors of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹64,659.1 Cr 0.4% -7.5% 11.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.4%

-7.5%

11.7%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses